GB0318113D0 - ›-Secretase enzyme compositions and methods - Google Patents

›-Secretase enzyme compositions and methods

Info

Publication number
GB0318113D0
GB0318113D0 GBGB0318113.8A GB0318113A GB0318113D0 GB 0318113 D0 GB0318113 D0 GB 0318113D0 GB 0318113 A GB0318113 A GB 0318113A GB 0318113 D0 GB0318113 D0 GB 0318113D0
Authority
GB
United Kingdom
Prior art keywords
methods
enzyme compositions
secretase enzyme
secretase
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0318113.8A
Other versions
GB2389182B (en
GB2389182A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Elan Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharmaceuticals LLC filed Critical Elan Pharmaceuticals LLC
Priority claimed from GB0121314A external-priority patent/GB2364059B/en
Publication of GB0318113D0 publication Critical patent/GB0318113D0/en
Publication of GB2389182A publication Critical patent/GB2389182A/en
Application granted granted Critical
Publication of GB2389182B publication Critical patent/GB2389182B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
GB0318113A 1999-02-10 2000-02-10 Method of purifying b-secretase Expired - Fee Related GB2389182B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11957199P 1999-02-10 1999-02-10
US13917299P 1999-06-15 1999-06-15
GB0121314A GB2364059B (en) 1999-02-10 2000-02-10 Beta-Secretase enzyme compositions and methods

Publications (3)

Publication Number Publication Date
GB0318113D0 true GB0318113D0 (en) 2003-09-03
GB2389182A GB2389182A (en) 2003-12-03
GB2389182B GB2389182B (en) 2004-02-04

Family

ID=29407316

Family Applications (3)

Application Number Title Priority Date Filing Date
GB0318113A Expired - Fee Related GB2389182B (en) 1999-02-10 2000-02-10 Method of purifying b-secretase
GB0318112A Expired - Fee Related GB2389114B (en) 1999-02-10 2000-02-10 Mouse b-secretase enzyme
GB0318107A Expired - Fee Related GB2389113B (en) 1999-02-10 2000-02-10 B-secretase inhibitor

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB0318112A Expired - Fee Related GB2389114B (en) 1999-02-10 2000-02-10 Mouse b-secretase enzyme
GB0318107A Expired - Fee Related GB2389113B (en) 1999-02-10 2000-02-10 B-secretase inhibitor

Country Status (1)

Country Link
GB (3) GB2389182B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115410B1 (en) 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
WO2000047618A2 (en) 1999-02-10 2000-08-17 Elan Pharmaceuticals, Inc. HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2005049027A2 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
WO2005075436A2 (en) 2004-02-05 2005-08-18 Probiodrug Ag Novel inhibitors of glutaminyl cyclase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872101A (en) * 1995-01-06 1999-02-16 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
JPH10155487A (en) * 1996-11-28 1998-06-16 Kagaku Gijutsu Shinko Jigyodan Amino acid sequence and dna sequence of protein combination having the same
WO1998026059A1 (en) * 1996-12-11 1998-06-18 Athena Neurosciences, Inc. Beta-secretase isolated from human 293 cells
GB9701684D0 (en) * 1997-01-28 1997-03-19 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
GB2389113A (en) 2003-12-03
GB2389182B (en) 2004-02-04
GB0318112D0 (en) 2003-09-03
GB2389113B (en) 2004-02-04
GB2389182A (en) 2003-12-03
GB2389114A (en) 2003-12-03
GB0318107D0 (en) 2003-09-03
GB2389114B (en) 2004-02-04

Similar Documents

Publication Publication Date Title
GB2364059B (en) Beta-Secretase enzyme compositions and methods
AUPQ419099A0 (en) Novel compositions and methods
GB9928968D0 (en) Enzyme
EP1165586A4 (en) TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
GB9920678D0 (en) Sanitising compositions and methods
EP1056456A4 (en) R-lansoprazole compositions and methods
GB9819979D0 (en) Sanitising compositions and methods
EP1056457A4 (en) S-lansoprazole compositions and methods
EP1156105A4 (en) Novel enzyme
EP1073333A4 (en) S-rabeprazole compositions and methods
GB0016744D0 (en) Novel enzyme
GB9906245D0 (en) Enzyme
AU6500600A (en) Methods and compositions for determining enzymatic activity
GB0318112D0 (en) ›-Secretase enzyme compositions and methods
EP1218393A4 (en) Cell targeting compositions and methods of using the same
GB9922135D0 (en) Compositions and uses
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
GB9807586D0 (en) Enzymes and their use
EP1073332A4 (en) R-rabeprazole compositions and methods
AU1477601A (en) Genetic compositions and methods
GB9924634D0 (en) Enzyme
AU5931300A (en) Ringene compositions and methods for use thereof
GB9908458D0 (en) Enzyme
AU7597400A (en) Methods and compositions utilizing rad51
AU3347300A (en) Desmethylsildenafil compositions and methods

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1062474

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1062474

Country of ref document: HK

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20110210